CA2454853A1 - Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier - Google Patents

Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier Download PDF

Info

Publication number
CA2454853A1
CA2454853A1 CA002454853A CA2454853A CA2454853A1 CA 2454853 A1 CA2454853 A1 CA 2454853A1 CA 002454853 A CA002454853 A CA 002454853A CA 2454853 A CA2454853 A CA 2454853A CA 2454853 A1 CA2454853 A1 CA 2454853A1
Authority
CA
Canada
Prior art keywords
conjugate
hapten
carrier
carbohydrate
aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002454853A
Other languages
English (en)
French (fr)
Inventor
Mark J. Krantz
B. Michael Longenecker
R. Rao Koganty
Ting Chi Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncothyreon Canada Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2454853A1 publication Critical patent/CA2454853A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/001172—Sialyl-Thomson-nouvelle antigen [sTn]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CA002454853A 2001-08-14 2002-08-05 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier Abandoned CA2454853A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31185001P 2001-08-14 2001-08-14
US60/311,850 2001-08-14
PCT/US2002/024735 WO2003015796A1 (en) 2001-08-14 2002-08-05 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier

Publications (1)

Publication Number Publication Date
CA2454853A1 true CA2454853A1 (en) 2003-02-27

Family

ID=23208785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002454853A Abandoned CA2454853A1 (en) 2001-08-14 2002-08-05 Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier

Country Status (6)

Country Link
US (1) US20040247608A1 (cg-RX-API-DMAC7.html)
EP (1) EP1429785A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005526692A (cg-RX-API-DMAC7.html)
CN (1) CN1543350A (cg-RX-API-DMAC7.html)
CA (1) CA2454853A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003015796A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080081045A1 (en) * 2003-10-14 2008-04-03 Biomira, Inc. Combination Therapy for Cancer
CN102276662B (zh) * 2010-06-09 2014-05-14 北京大学 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用
EP3046588B1 (en) 2013-09-17 2022-03-02 OBI Pharma, Inc. Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
MY188880A (en) * 2014-09-15 2022-01-12 Obi Pharma Inc Immunogenic/therapeutic glycoconjugate compositions and uses thereof
EP3344806A4 (en) 2015-09-04 2019-03-20 OBI Pharma, Inc. GLYCANARRAYS AND METHOD OF USE
AU2017239637A1 (en) 2016-03-29 2018-11-15 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
IL262296B2 (en) 2016-04-22 2024-09-01 Obi Pharma Inc Cancer immunotherapy by immune activation or immune modulation via globo series antigens
KR20190067765A (ko) 2016-07-27 2019-06-17 오비아이 파머 인코퍼레이티드 면역원성/치료 글리칸 조성물 및 그의 용도
KR102528998B1 (ko) 2016-07-29 2023-05-03 오비아이 파머 인코퍼레이티드 인간 항체, 제약 조성물 및 방법
CN106645697A (zh) * 2016-11-09 2017-05-10 百奥森(江苏)食品安全科技有限公司 一种食品中玉米赤霉醇的检测试剂盒
CN106526188A (zh) * 2016-11-09 2017-03-22 百奥森(江苏)食品安全科技有限公司 一种食品中沙丁胺醇的检测试剂盒
WO2018094414A1 (en) 2016-11-21 2018-05-24 Obi Pharma, Inc. Conjugated biological molecules, pharmaceutical compositions and methods
TW202504930A (zh) 2018-06-27 2025-02-01 台灣浩鼎生技股份有限公司 用於糖蛋白工程的糖苷合成酶變體及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407912A (en) * 1993-04-19 1995-04-18 Akzo, N.V. Method of treating bladder cancer with a keyhole limpet hemocyanin composition with enhanced anti-tumor activity
AU2247095A (en) * 1994-04-12 1995-10-30 Biomira Inc. Cellular immune response-specific antigens and uses therefor
WO1995029927A2 (en) * 1994-05-02 1995-11-09 Biomira, Inc. Process for preparation of glycosides of tumor-associated carbohydrate antigens
EP1091751A4 (en) * 1998-03-25 2005-01-19 Sloan Kettering Institutefor C TRIMERIC OXYGENIC BINDING GLYCOPEPTIDE CONJUGATES, METHODS OF PREPARATION AND USE THEREOF

Also Published As

Publication number Publication date
JP2005526692A (ja) 2005-09-08
EP1429785A1 (en) 2004-06-23
WO2003015796A1 (en) 2003-02-27
EP1429785A4 (en) 2005-12-14
US20040247608A1 (en) 2004-12-09
CN1543350A (zh) 2004-11-03

Similar Documents

Publication Publication Date Title
US20040247608A1 (en) Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
Avci et al. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
JP6784646B2 (ja) アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン
Yarovinsky et al. Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response
US11904002B2 (en) Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines
EP1379552B1 (en) Toll-like receptor 5 ligands and methods of use
EP3046588B1 (en) Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
CZ20022748A3 (cs) Nová metoda regulace obsahu amyloidu
KR102702705B1 (ko) 면역원성/치료적 당접합체 조성물 및 그의 용도
SK287468B6 (sk) Použitie analógu autológneho Aß alebo APP polypeptidu živočícha, analóg, fragment nukleovej kyseliny, vektor, transformovaná bunka, bunková línia a kompozície
JP2004538332A (ja) β−アミロイドアナログ−T細胞エピトープワクチン
KR20230080397A (ko) 알츠하이머 질환을 치료하기 위한 멀티에피토프 백신
JPH10510424A (ja) レクザイム及び糖質リガンドの同定浄化及び使用
US11708411B2 (en) Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
JPH07505365A (ja) 耐性の誘導に有用なペプチド
KR20230087487A (ko) 시누클레인 병증을 치료하기 위한 α-시누클레인 백신
JP2023525276A (ja) 延長された酸化還元酵素モチーフを有する免疫原性ペプチド
WO1995027505A1 (en) Cellular immune response-specific antigens and uses therefor
US20260097104A1 (en) Methods of Formulating a Vaccine
AU2002319755A1 (en) Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier
US20240238414A1 (en) Anti-parasitic immunological compositions
US9358302B2 (en) Glycoconjugate vaccines
KR20130106786A (ko) 골수유래억제세포 및 레바미피드를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
US20250041278A1 (en) Tlr8 agonist for modulating immune response
US20250000971A1 (en) Tlr4 agonist for modulating immune response

Legal Events

Date Code Title Description
FZDE Discontinued